German researchers say they have started phase 2 trials of a new cancer vaccine.
The research is being led by pharmaceutical company BioNTech - the same firm behind the successful Covid-19 vaccine developed in partnership with pfizer.
It's new vaccine trials will target colorectal cancer- the second deadliest cancer worldwide, which commonly affects the bowel, colon and rectum.
From Berlin, Trent Murray reports.
IN: BioNTech has
OUT: SOC
TIME: 48 seconds
It's new vaccine trials will target colorectal cancer- the second deadliest cancer worldwide, which commonly affects the bowel, colon and rectum.
From Berlin, Trent Murray reports.
IN: BioNTech has
OUT: SOC
TIME: 48 seconds